Showing results (2291-2300 of 6,159) with videos related to
Sort By:
Pageof 616
Nature Medicine|January 8, 2025
Angiogenic factors versus fetomaternal Doppler for fetal growth restriction at term: an open-label, randomized controlled trialPablo Garcia-Manau, Erika Bonacina, Raquel Martin-Alonso, et al.Nature Medicine|January 6, 2025
Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical dataSeong-Keun Yoo, Conall W Fitzgerald, Byuri Angela Cho, et al.Nature Medicine|January 3, 2025
Empagliflozin in nondiabetic individuals with calcium and uric acid kidney stones: a randomized phase 2 trialManuel A Anderegg, Simeon Schietzel, Matteo Bargagli, et al.Nature Medicine|January 3, 2025
Effects of conditional cash transfers on tuberculosis incidence and mortality according to race, ethnicity and socioeconomic factors in the 100 Million Brazilian CohortGabriela S Jesus, Priscila F P S Gestal, Andrea F Silva, et al.Nature Medicine|January 3, 2025
Sustained virologic suppression of multidrug-resistant HIV in an individual treated with anti-CD4 domain 1 antibody and lenacapavirM Ali Rai, Jana Blazkova, Lela Kardava, et al.Nature Medicine|January 3, 2025
Proteomic changes upon treatment with semaglutide in individuals with obesityLasse Maretty, Dipender Gill, Lotte Simonsen, et al.Nature Medicine|January 3, 2025
Single immunization with genetically attenuated Pf∆mei2 (GA2) parasites by mosquito bite in controlled human malaria infection: a placebo-controlled randomized trialGeert V T Roozen, Roos van Schuijlenburg, Annefleur D O Hensen, et al.Nature Medicine|January 3, 2025
Multi-omic profiling a defined bacterial consortium for treatment of recurrent Clostridioides difficile infectionRajita Menon, Shakti K Bhattarai, Emily Crossette, et al.Nature Medicine|March 11, 2025
Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trialRaajit K Rampal, Sebastian Grosicki, Dominik Chraniuk, et al.Nature Medicine|April 8, 2025
Mechanisms of hematopoietic clonal dominance in VEXAS syndromeRaffaella Molteni, Martina Fiumara, Corrado Campochiaro, et al.Pageof 616